Biotron Limited Net Income

The latest net income for BITRF is $-1.8M as of June 2026. That compares with $-6.9M in the prior-year period — up 73.5% year over year. That is below the Healthcare sector average of $82B. Investors often review this figure alongside Biotron Limited's historical trend and sector peers before judging valuation or financial health.

Over the past year, BITRF's net income moved from $-6.9M to $-1.8M — a 73.5% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Biotron Limited's operating scale or balance-sheet position.

Against Healthcare companies, BITRF currently prints $-1.8M for net income, while the sector average sits near $82B. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at Biotron Limited's growth, margins, and balance sheet.

A net income figure of $-1.8M for BITRF is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $82B. Explore the charts below for those layers of context.

After noting BITRF's net income ($-1.8M), review year-over-year change from $-6.9M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.